The Molecular Imaging and Radiotheranostics (MIRA) Laboratory focuses on harnessing the power of radiation to solve disease management problems. We work on 3 major areas: (i) molecular imaging of diseases and disease processes with radiolabeled moieties and imaging of the immune system with a peptide that targets activated CD8 T cells, (ii) radiopharmaceutical therapy using small molecules/antibodies/peptides radiolabeled with alpha or beta emitters for curative cancer treatment and its combination with other treatment modalities such as immune checkpoint inhibitors and DNA damage inhibitors and (iii) radioimmunobiology by evaluating the immunomodulatory effects of radiation and how can  radiation be used to modulate the tumor microenvironment.